0001968202-24-000072.txt : 20240226 0001968202-24-000072.hdr.sgml : 20240226 20240226160725 ACCESSION NUMBER: 0001968202-24-000072 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240222 FILED AS OF DATE: 20240226 DATE AS OF CHANGE: 20240226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SING GEORGE L CENTRAL INDEX KEY: 0001225471 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 24678722 MAIL ADDRESS: STREET 1: LANCET CAPITAL STREET 2: 45 ROCKEFELLER PLAZA STE 2008 CITY: NEW YORK STATE: NY ZIP: 10111 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0508 4 2024-02-22 0 0000872589 REGENERON PHARMACEUTICALS, INC. REGN 0001225471 SING GEORGE L 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 1 0 0 0 0 Common Stock 2024-02-22 4 M 0 1000 413.33 A 27349 D Common Stock 2024-02-22 4 S 0 1000 970.0 D 26349 D Common Stock 2024-02-22 4 M 0 1000 413.33 A 27349 D Common Stock 2024-02-22 4 S 0 1000 965.0 D 26349 D Common Stock 2024-02-22 4 M 0 1000 413.33 A 27349 D Common Stock 2024-02-22 4 S 0 1000 960.0 D 26349 D Common Stock 2024-02-23 4 M 0 500 413.33 A 26849 D Common Stock 2024-02-23 4 S 0 500 985.0 D 26349 D Common Stock 750 I by Spouse Common Stock 400 I by Spouse/Cust Son Common Stock 1000 I by Trust for Son Non-Qualified Stock Option (right to buy) 413.33 2024-02-22 4 M 0 3000 0.0 D 2025-01-02 Common Stock 3000 6838 D Non-Qualified Stock Option (right to buy) 413.33 2024-02-23 4 M 0 500 0.0 D 2025-01-02 Common Stock 500 6338 D The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant. /s/**George L. Sing 2024-02-26